Eric Topol October 13, 2024

At the Interface of biomedical science and A.I.

When I think of digital biology, I think of Patrick Hsu—he’s the prototype, a rarified talent in both life and computer science, who recently led the team that discovered bridge RNAs, what may be considered CRISPR 3.0 for genome editing, and is building new generative A.I. models for life science. You might call them LLLMs-large language of life models. He is Co-Founder and a Core Investigator of the Arc Institute and Assistant Professor of Bioengineering and Deb Faculty Fellow at the University of California, Berkeley.

Above is a brief snippet of our conversation. Full videos of all Ground Truths podcasts can be seen on YouTube here. The audios are also available on...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Conferences / Podcast, Pharma / Biotech, Technology, Trends
Sanofi, expanding in radiopharma, strikes a joint venture deal
Sage to cut one-third of workforce, streamline drug pipeline
After rejections, AbbVie secures approval for Parkinson’s drug
Wave surges on first RNA editing data in humans
Lexicon sells Viatris rights to cardio drug outside of the U.S. and Europe

Share This Article